166 related articles for article (PubMed ID: 16777497)
1. Cu(II) induces small-size aggregates with amyloid characteristics in two alleles of recombinant ovine prion proteins.
Tsiroulnikov K; Rezaei H; Dalgalarrondo M; Chobert JM; Grosclaude J; Haertlé T
Biochim Biophys Acta; 2006 Jul; 1764(7):1218-26. PubMed ID: 16777497
[TBL] [Abstract][Full Text] [Related]
2. Copper induces increased beta-sheet content in the scrapie-susceptible ovine prion protein PrPVRQ compared with the resistant allelic variant PrPARR.
Wong E; Thackray AM; Bujdoso R
Biochem J; 2004 May; 380(Pt 1):273-82. PubMed ID: 14969585
[TBL] [Abstract][Full Text] [Related]
3. Copper(II) inhibits in vitro conversion of prion protein into amyloid fibrils.
Bocharova OV; Breydo L; Salnikov VV; Baskakov IV
Biochemistry; 2005 May; 44(18):6776-87. PubMed ID: 15865423
[TBL] [Abstract][Full Text] [Related]
4. Formation of soluble oligomers and amyloid fibrils with physical properties of the scrapie isoform of the prion protein from the C-terminal domain of recombinant murine prion protein mPrP-(121-231).
Martins SM; Frosoni DJ; Martinez AM; De Felice FG; Ferreira ST
J Biol Chem; 2006 Sep; 281(36):26121-8. PubMed ID: 16844683
[TBL] [Abstract][Full Text] [Related]
5. Osmolyte trimethylamine N-oxide converts recombinant alpha-helical prion protein to its soluble beta-structured form at high temperature.
Nandi PK; Bera A; Sizaret PY
J Mol Biol; 2006 Sep; 362(4):810-20. PubMed ID: 16949096
[TBL] [Abstract][Full Text] [Related]
6. PrP N-terminal domain triggers PrP(Sc)-like aggregation of Dpl.
Erlich P; Cesbron JY; Lemaire-Vieille C; Curt A; Andrieu JP; Schoehn G; Jamin M; Gagnon J
Biochem Biophys Res Commun; 2008 Jan; 365(3):478-83. PubMed ID: 17997980
[TBL] [Abstract][Full Text] [Related]
7. Conformational variation between allelic variants of cell-surface ovine prion protein.
Thackray AM; Yang S; Wong E; Fitzmaurice TJ; Morgan-Warren RJ; Bujdoso R
Biochem J; 2004 Jul; 381(Pt 1):221-9. PubMed ID: 15070397
[TBL] [Abstract][Full Text] [Related]
8. Mapping of possible prion protein self-interaction domains using peptide arrays.
Rigter A; Langeveld JP; Timmers-Parohi D; Jacobs JG; Moonen PL; Bossers A
BMC Biochem; 2007 Apr; 8():6. PubMed ID: 17430579
[TBL] [Abstract][Full Text] [Related]
9. Absolute and relative quantification of sheep brain prion protein (PrP) allelic variants by matrix-assisted laser desorption/ionisation time-of-flight mass spectrometry.
Morel N; Andréoletti O; Grassi J; Clément G
Rapid Commun Mass Spectrom; 2007; 21(24):4093-100. PubMed ID: 18008391
[TBL] [Abstract][Full Text] [Related]
10. Molecular architecture of human prion protein amyloid: a parallel, in-register beta-structure.
Cobb NJ; Sönnichsen FD; McHaourab H; Surewicz WK
Proc Natl Acad Sci U S A; 2007 Nov; 104(48):18946-51. PubMed ID: 18025469
[TBL] [Abstract][Full Text] [Related]
11. Nanopore analysis reveals differences in structural stability of ovine PrP(C) proteins corresponding to scrapie susceptible (VRQ) and resistance (ARR) genotypes.
Madampage CA; Marciniuk K; Määttänen P; Cashman NR; Potter A; Lee JS; Napper S
Prion; 2013; 7(6):511-9. PubMed ID: 24401607
[TBL] [Abstract][Full Text] [Related]
12. Self-assembly of recombinant prion protein of 106 residues.
Baskakov IV; Aagaard C; Mehlhorn I; Wille H; Groth D; Baldwin MA; Prusiner SB; Cohen FE
Biochemistry; 2000 Mar; 39(10):2792-804. PubMed ID: 10704232
[TBL] [Abstract][Full Text] [Related]
13. Assembly of natural and recombinant prion protein into fibrils.
Leffers KW; Wille H; Stöhr J; Junger E; Prusiner SB; Riesner D
Biol Chem; 2005 Jun; 386(6):569-80. PubMed ID: 16006244
[TBL] [Abstract][Full Text] [Related]
14. Conformation dependent pro-apoptotic activity of the recombinant human prion protein fragment 90-231.
Corsaro A; Paludi D; Villa V; D'Arrigo C; Chiovitti K; Thellung S; Russo C; Di Cola D; Ballerini P; Patrone E; Schettini G; Aceto A; Florio T
Int J Immunopathol Pharmacol; 2006; 19(2):339-56. PubMed ID: 16831301
[TBL] [Abstract][Full Text] [Related]
15. Differential effects of divalent cations on elk prion protein fibril formation and stability.
Samorodnitsky D; Nicholson EM
Prion; 2018 Jan; 12(1):63-71. PubMed ID: 29310497
[TBL] [Abstract][Full Text] [Related]
16. Detailed biophysical characterization of the acid-induced PrP(c) to PrP(β) conversion process.
Bjorndahl TC; Zhou GP; Liu X; Perez-Pineiro R; Semenchenko V; Saleem F; Acharya S; Bujold A; Sobsey CA; Wishart DS
Biochemistry; 2011 Feb; 50(7):1162-73. PubMed ID: 21189021
[TBL] [Abstract][Full Text] [Related]
17. On the mechanism of alpha-helix to beta-sheet transition in the recombinant prion protein.
Morillas M; Vanik DL; Surewicz WK
Biochemistry; 2001 Jun; 40(23):6982-7. PubMed ID: 11389614
[TBL] [Abstract][Full Text] [Related]
18. Autocatalytic conversion of recombinant prion proteins displays a species barrier.
Baskakov IV
J Biol Chem; 2004 Feb; 279(9):7671-7. PubMed ID: 14668351
[TBL] [Abstract][Full Text] [Related]
19. A new paradigm for enzymatic control of α-cleavage and β-cleavage of the prion protein.
McDonald AJ; Dibble JP; Evans EG; Millhauser GL
J Biol Chem; 2014 Jan; 289(2):803-13. PubMed ID: 24247244
[TBL] [Abstract][Full Text] [Related]
20. N-homocysteinylation of ovine prion protein induces amyloid-like transformation.
Stroylova YY; Chobert JM; Muronetz VI; Jakubowski H; Haertlé T
Arch Biochem Biophys; 2012 Oct; 526(1):29-37. PubMed ID: 22782079
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]